Technologies
Title: | A Gene Chip Based Predictive Biomarker for Oral Cancer Metastasis |
Area: | Medical Sciences |
Focus Area: | Cancer Treatment |
Patent: | IN201811018135 |
Social Benefits: | Will allow to detect whether or not an early stage oral tumor has nodal metastasis, This will help onco-surgeon to decide whether not to de aggresive surgery, Approxomate number of early stage oral cancer pateint would be 75,000/year , Projeted market value would be 150cr/year(assuming an asay cost of Rs. 20,000/-) |
Developing Agency: | CSIR-Indian Institute of Chemical Biology (IICB), West Bengal |
Technology Readiness Index: | Technology Development |
Email: | director@iicb.res.in |
| Website Link : | http://www.iicb.res.in |
| Source (more info) : | https://t.ly/l_sb |
Brief Description
Description : | A gene expression chip comprised of 34 genes that predict nodal metastatic subset of early stage oral cancer with high specificity. Will allow to detect whether or not an early stage oral tumor has nodal metastasis, help Onco Surgeon to decide whether not to do aggressive surgery. |